24
https://pubmed.ncbi.nlm.nih.gov/38112325
This study used computational methods to analyze the binding of morpholino-pyrimidine inhibitors to the TB drug target DprE1, finding that specific interactions and structural changes contribute to the inhibitors’ potency, and suggesting modifications to further enhance their activity.